BioLight Life Sciences
Sector: Healthcare & Life Sciences
About BioLight Life Sciences
Investment firm with a focus in Ophthalmology. BioLight's current and future portfolio companies engage in advanced medical devices, medication, diagnostics and digital healthcare, exemplifying the enormous potential of “Israeli Innovation in Ophthalmology” with a special focus on converging Ophthalmology with Engineering. the need for Innovation in Ophthalmology Population growth and aging worldwide, as well as the environment’s increasing factors harming eye health (UV exposure, computer screens etc.) escalate the need for innovative and effective solutions for the treatment of eye diseases. Development and commercialization of the company’s ophthalmic technologies and products The ophthalmic products developed by the companies in the BioLight group are aimed at innovative diagnosis and technological advancements. Several of our ophthalmic products are in various commercialization and clinical (or pre-clinical) phases. Portfolio includes treatments for Glaucoma, Dry Eye Syndrome, and diagnostics for ocular surface diseases. (TASE:BOLT)